E, A., T, K., R, E., D, O., E, T., V, Y., & R, T. (2025). B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis. In vivo (Athens, Greece), 39(2), 1162. https://doi.org/10.21873/invivo.13920
Chicago Style (17th ed.) CitationE, Akbayir, Kizilay T, Erol R, Ozkan-Yasargun D, Tuzun E, Yilmaz V, and Turkoglu R. "B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis." In Vivo (Athens, Greece) 39, no. 2 (2025): 1162. https://doi.org/10.21873/invivo.13920.
MLA (9th ed.) CitationE, Akbayir, et al. "B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis." In Vivo (Athens, Greece), vol. 39, no. 2, 2025, p. 1162, https://doi.org/10.21873/invivo.13920.